Current role
Biotechnology · Healthcare
Board Member
2025-09-23–present
John Holcomb
Board Member
MiNK Therapeutics, Inc. (INKT)Equibles does not estimate personal net worth.
Get an email with a short summary when MiNK Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get INKT alertsAbout John Holcomb
John Holcomb is recorded as Board Member at MiNK Therapeutics, Inc. (INKT) since September 23, 2025. MiNK Therapeutics, Inc. reported in an 8-K filed September 29, 2025 that John Holcomb was appointed Class II director, effective September 23, 2025. MiNK Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MiNK Therapeutics, Inc. includes Melissa Orilall (CFO), Austin Charette (Chief Accounting Officer), Dr. John Holcomb (Board Member) and 4 others.
“On September 23, 2025, the Board of Directors (the "Board") of MiNK Therapeutics, Inc., ("MiNK") elected Dr. John Holcomb to become a Class II director of MiNK with an initial term that expires at MiNK's annual meeting of stockholders in 2026.”
Affiliation history
-
Current
2025-09-23–present
Company network
Leadership on record at MiNK Therapeutics, Inc.
- Melissa Orilall CFO
- Austin Charette Chief Accounting Officer
- Dr. John Holcomb Board Member
- Jennifer Buell Board Member
- Peter Behner Board Member
- Robert Kadlec Board Member
- Ulf Wiinberg Board Member